OFIX · Orthofix Medical Inc. · Documents

$8.92 -0.80 (-8.23%) At close · Nov 5 Play latest call Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$392.26M

40.73M

Volume · Nov 5 1.36M Avg daily vol (3M) 404.83K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024

Apr 29

Proxy statement DEF 14A

Proxy statement

Apr 29

Proxy statement DEFA14A

Proxy statement

Apr 22

Current report 8-K Events of Apr 19

Entered into a material agreement

Apr 12

Current report 8-K Events of Apr 11

Director or officer change, or executive pay

Mar 5

Earnings call

Q4 2023 earnings call

Mar 5

Current report 8-K

Financial results, Regulation FD disclosure

Mar 5

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $746.64M ▲ 62.1% Net loss $151.4M Diluted EPS -$4.12

Jan 17

Current report 8-K Events of Jan 15

Director or officer change, or executive pay, Regulation FD disclosure

Jan 9

Current report 8-K Events of Jan 8

Financial results, Director or officer change, or executive pay

Jan 8

Current report 8-K

Regulation FD disclosure

2023

Dec 15

Current report 8-K Events of Dec 11

Entered into a material agreement, Director or officer change, or executive pay, Other events

Dec 1

Current report 8-K Events of Nov 27

Director or officer change, or executive pay, Regulation FD disclosure

Nov 8

Earnings call

Q3 2023 earnings call

Nov 8

Current report 8-K Events of Nov 6

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation

Nov 8

Current report 8-K

Financial results, Regulation FD disclosure

Nov 8

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $184.01M ▲ 61.4% Net loss $28.86M Diluted EPS -$0.77

Oct 5

Current report 8-K Events of Oct 4

Director or officer change, or executive pay

Oct 3

Current report 8-K Events of Sep 27

Director or officer change, or executive pay

Sep 14

Current report 8-K Events of Sep 11

Director or officer change, or executive pay, Regulation FD disclosure, Other events

Aug 8

Earnings call

Q2 2023 earnings call

Aug 8

Current report 8-K

Financial results, Regulation FD disclosure

Aug 8

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $187.02M ▲ 58.4% Net loss $39.43M Diluted EPS -$1.07

Jun 21

Current report 8-K Events of Jun 19

Director or officer change, or executive pay

Jun 20

Current report 8-K Events of Jun 19

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events

Jun 15

Current report 8-K Events of Jun 13

Current report

May 9

Earnings call

Q1 2023 earnings call

May 9

Current report 8-K

Financial results, Regulation FD disclosure

May 9

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $175.2M ▲ 64.6% Net loss $60.94M Diluted EPS -$1.71

Apr 27

Proxy statement DEF 14A

Proxy statement

Apr 27

Proxy statement DEFA14A

Proxy statement

Apr 18

Proxy statement PRE 14A

Proxy statement

Apr 7

Current report 8-K Events of Apr 4

Director or officer change, or executive pay

Mar 13

Current report 8-K

Regulation FD disclosure

Mar 6

Earnings call

Q4 2022 earnings call

Mar 6

Current report 8-K

Financial results, Regulation FD disclosure

Mar 6

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $460.71M ▼ 0.8% Net loss $19.75M Diluted EPS -$0.98

Feb 13

Current report 8-K/A Events of Jan 5

Current report

Jan 9

Current report 8-K

Financial results

Jan 5

Current report 8-K Events of Jan 3

Ended a material agreement, Completed an acquisition or sale of assets, New debt or off-balance-sheet obligation, Director or officer change, or executive pay, Other events

Jan 4

Current report 8-K

Shareholder vote results

2022

Dec 27

Current report 8-K

Other events

Dec 5

Current report 8-K

Other events

Nov 30

Current report 8-K

Other events

Nov 22

Registration statement S-4/A

Registration statement

Nov 21

Current report 8-K Events of Nov 17

Other events

Nov 8

Registration statement S-4

Registration statement

Nov 3

Earnings call

Q3 2022 earnings call

Nov 3

Current report 8-K

Financial results, Regulation FD disclosure

Nov 3

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $114M ▲ 1.4% Net loss $10.72M Diluted EPS -$0.53

Oct 11

Current report 8-K Events of Oct 10

Entered into a material agreement, Charter or bylaw amendment, or fiscal year change, Other events

Showing 51–100 of 160 documents

Key facts CIK 884624 CUSIP 68752M108 13F (30d) 47 filings 35 filers Visit website Investor relations